In the Ryanodex-treated mice, we see a restoration of synaptic integrity, as well as normalized PSD95 and synaptophysin immunostaining levels in the 3xTg-AD mice, with no effects in NonTg mice. The gene discussed is SYP; the disease is Alzheimer disease.